Non-susceptibility to tigecycline in enterococci from hospitalised patients, food products and community sources

Archive ouverte

Freitas, Ana R. | Novais, Carla | Correia, Rosa | Monteiro, Márcia | Coque, Teresa M. | Peixe, Luísa

Edité par CCSD ; Elsevier -

International audience. In this study, the in vitro activity of tigecycline against 1140 enterococci collected from humans, food products, animals and the environment in Portugal (1996-2008) was analysed. Ten isolates (seven and three spp.) non-susceptible to tigecycline (minimum inhibitory concentrations of 0.5-1.0mg/L), which were also resistant to tetracycline and minocycline, were mostly observed in samples collected before the introduction of tigecycline in the therapeutic arsenal. The isolates were recovered from hospitalised patients (=2; ST319/CC2 and ST34), healthy humans (=2; ST21/CC21), chicken meat (=1; ST260) as well as from two swine samples. The remaining isolates were also recovered from chicken meat (=1; ) and swine (=2; and spp.). Recovery of enterococcal isolates with reduced susceptibility to tigecycline among different reservoirs, including animals for food consumption, suggests that selection of tigecycline-resistant isolates by antibiotics other than tigecycline might occur in non-clinical settings.

Suggestions

Du même auteur

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe Towards a common nomenclature

Archive ouverte | Bender, Jennifer K | CCSD

International audience. Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptid...

In-depth resistome analysis by targeted metagenomics

Archive ouverte | Lanza, Val F. | CCSD

METHODOLOGY. International audience. Background: Antimicrobial resistance is a major global health challenge. Metagenomics allows analyzing the presence and dynamics of "resistomes" (the ensemble of genes encoding a...

Chargement des enrichissements...